Home > National Drug Code (NDC) > ALDACTAZIDE

ALDACTAZIDE - 0025-1021-31 - (SPIRONOLACTONE and HYDROCHLOROTHIAZIDE)

Alphabetical Index


Drug Information of ALDACTAZIDE

Product NDC: 0025-1021
Proprietary Name: ALDACTAZIDE
Non Proprietary Name: SPIRONOLACTONE and HYDROCHLOROTHIAZIDE
Active Ingredient(s): 50; 50    mg/1; mg/1 & nbsp;   SPIRONOLACTONE and HYDROCHLOROTHIAZIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of ALDACTAZIDE

Product NDC: 0025-1021
Labeler Name: G.D. Searle LLC Division of Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA012616
Marketing Category: NDA
Start Marketing Date: 19780101

Package Information of ALDACTAZIDE

Package NDC: 0025-1021-31
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE (0025-1021-31)

NDC Information of ALDACTAZIDE

NDC Code 0025-1021-31
Proprietary Name ALDACTAZIDE
Package Description 100 TABLET, FILM COATED in 1 BOTTLE (0025-1021-31)
Product NDC 0025-1021
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SPIRONOLACTONE and HYDROCHLOROTHIAZIDE
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19780101
Marketing Category Name NDA
Labeler Name G.D. Searle LLC Division of Pfizer Inc
Substance Name HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Strength Number 50; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of ALDACTAZIDE


General Information